InSphero provides superior biological relevance to in vitro cell culture methods for drug discovery and compound testing with easy-to-use solutions for production, culture and assessment of organotypic 3D cell culture models. Founded in 2009, the company's patented 3D cell culture platforms and methods enable large-scale, reproducible production of a broad range of assay-ready 3D InSight™ Microtissues including models derived from liver, pancreas, tumor, heart, brain, and skin. InSphero is headquartered in Schlieren (a suburb of Zurich, Switzerland), with subsidiaries in the United States (Brunswick, ME) and Waldshut, Germany. InSphero has been recognized for its scientific and commercial achievements with a number of national and international awards.
InSphero does not currently accept candidates from recruiters.